LONDON - March 19, 2019 - (Newswire.com)
According to the latest publication from Meticulous Research®, the global breast imaging market will grow at a CAGR of 8.8 percent from 2019 to reach $5.2 billion by 2024, driven by rising prevalence and incidence of breast cancer, growing awareness for early detection of breast diseases, technological advancements in breast imaging equipment, increasing investment and funding in R&D for breast cancer treatment, rising women aging population, and launch of advanced systems and software for diagnosing dense breast tissue.
Traditionally, various end users were using analog mammography systems. However, this trend is shifting towards digital mammography systems due to their advantages such as high detection rate coupled with breast cancer incidences.
On the basis of technology, ionizing technology commanded the largest share. However, non-ionizing technology will grow at the highest CAGR during the forecast period due to their advantages such as accurate detection of breast tumor location and higher sensitivity for smaller breast lesion in dense breast women.
For more insights on global Breast Imaging Market, download sample free report here: https://www.meticulousresearch.com/download-sample-report/cp_id=4959
The breast imaging market is segmented based on technology- ionizing (full-field digital mammography (FFDM), analog mammography, 3D breast tomosynthesis (DBT), positron emission tomography/computed tomography (PET/CT), molecular breast-specific gamma imaging (MBI/BSGI), positron emission mammography (PEM), computed tomography (CT), cone beam computed tomography (CBCT), and electric impedance tomography (EIT); and non-ionizing- breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBS), breast thermography, and optical imaging; and end user (hospitals, diagnostic imaging centers, and ambulatory surgical centres).
Based on end user, hospitals accounted for the largest share due to higher purchasing power, well-equipped operating & diagnostic rooms, presence of highly skilled healthcare professionals, ease in accessibility, and better health coverage for hospital based healthcare services from various private and group insurance plans. On the other hand, Ambulatory Surgical Centers (ASCs) are expected to grow at a fastest CAGR owing to rising preference for outpatient services, quick arrangement of surgery for critical breast cancer patients by eliminating the waiting time at hospitals, most surgery payments to be covered by ASC payment systems, greater autonomy of ASC physicians, and rising number of surgeries performed across ASCs.
On the basis of geography, Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth will be mainly due to accelerated economic growth of many countries, growing government focus on healthcare sector, rising incidence & prevalence of breast tumor, increasing health insurance penetration, and a rising female aging population in the region.
Key players operating in the global breast imaging market include Hologic, Inc., GE Healthcare, Siemens Healthcare GmbH, Carestream Health Inc., Koninklijke Philips N.V., FUJIFILM Holdings America Corporation, Canon Medical Systems Corporation, Hitachi Medical Systems, Aurora healthcare US Corporation, Dilon Technologies, Inc., CMR Naviscan Corporation, Planmed Oy, and SonoCine Inc. among others.
Key Topics Covered in This Report:
1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insight
4.1. Introduction
4.2. Drivers
4.2.1. Rising Prevalence and Incidence of Breast Cancer
4.2.2. Growing Awareness for Early Detection of Breast Diseases
4.2.3. Technological Advancements in Breast Imaging Equipment
4.2.4. Increasing Investment and Funding in R&D for Breast Cancer Treatment
4.2.5. Rising Women Aging Population
4.2.6. Launch of Advanced System and Software for Diagnosing Dense Breast Tissue
4.3. Restraints
4.3.1. High Cost of Breast Imaging Equipment
4.3.2. Errors Associated with Breast Screening and Diagnosing
4.3.3. Stringent Regulatory Approval Procedure
4.4. Opportunities
4.4.1. Extensive Research in the Development of Hybrid Imaging Systems
5. Global Breast Imaging Market, by Technology
5.1. Introduction
5.2. Ionizing Technology
5.2.1. Full-Field Digital Mammography (FFDM)
5.2.2. Analog Mammography
5.2.3. 3d Breast Tomosynthesis
5.2.4. Positron Emission Tomography/Computed Tomography (PET/CT)
5.2.5. Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
5.2.6. Positron Emission Mammography (PEM)
5.2.7. Computed Tomography (CT)
5.2.8. Cone Beam Computed Tomography (CBCT)
5.2.9. Electric Impedance Tomography (EIT)
5.3. Non- Ionizing Technology
5.3.1. Breast Ultrasound
5.3.2. Breast MRI
5.3.3. Automated Whole-Breast Ultrasound (AWBU)
5.3.4. Breast Thermography
5.3.5. Optical Imaging
6. Global Breast Imaging Market, by End User
6.1. Introduction
6.2. Hospitals
6.3. Diagnostic Imaging Centers
6.4. Academic and Research Institutes
6.5. Ambulatory Surgical Centers (ASCs)
7. Breast Imaging Market, by Geography
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Rest of Europe (RoE)
7.4. Asia-Pacific
7.4.1. Japan
7.4.2. China
7.4.3. India
7.4.4. Rest of Asia-Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa
8. Competitive Landscape
8.1. Competitive Benchmarking
9. Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
9.1. Hologic, Inc.
9.2. GE Healthcare
9.3. Siemens Healthcare GmbH (Subsidiary of Siemens AG)
9.4. Carestream Health, Inc.
9.5. Koninklijke Philips N.V.
9.6. Fujifilm Holdings America Corporation (Subsidiary of Fujifilm Holding Corporation)
9.7. Canon Medical Systems Corporation (Subsidiary of Canon Inc.)
9.8. Hitachi Healthcare Americas Ltd (Subsidiary of Hitachi Medical Corporation)
9.9. Aurora Healthcare US Corporation
9.10. Dilon Technologies, Inc.
9.11. CMR Naviscan Corporation
9.12. Planmed Oy
9.13. SonoCine Inc.
10. Appendix
10.1. Questionnaire
10.1. Available Customization
For more insights on global Breast Imaging Market, download sample free report here: https://www.meticulousresearch.com/download-sample-report/cp_id=4959
Contact Info:
Khushal Bombe
Email: sales@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Related Links
Breast Imaging Market - Global Opportunity Analysis and Industry Forecast (2019 - 2024)
Breast Imaging Market worth $5.2 Billion by 2024
Press Release Service by Newswire.com
Original Source: Breast Imaging Market Worth $5.2 Billion by 2024 - Exclusive Report by Meticulous Research®
